Inverse agonism gains weight

Trends in Pharmacological Sciences

Volumn 24, Issue 6, 2003, Pages 315-321

  Adan, Roger A H ^a   Kas, Martien J H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; APPETITE STIMULANT; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR;

BODY WEIGHT; FOOD INTAKE; HUMAN; IN VIVO STUDY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 0037665970     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00130-5     Document Type: Review

References (43)

1. Strange P.G. Mechanisms of inverse agonism at G-protein-coupled receptors. Trends Pharmacol. Sci. 23:2002;89-95.
2. Nijenhuis W.A., et al. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 15:2001;164-171.
3. Haskell-Luevano C., Monck E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99:2001;1-7.
4. Duhl D.M., et al. Neomorphic Agouti mutations in obese yellow mice. Nat. Genet. 8:1994;59-65.
5. Lu D., et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 371:1994;799-802.
6. Ollmann M.M., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
7. Shutter J.R., et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
8. Schwartz M.W., et al. Central nervous system control of food intake. Nature. 404:2000;661-671.
9. Arvaniti K., et al. Effects of leptin and corticosterone on the expression of corticotropin-releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse. Neuroendocrinology. 73:2001;227-236.
10. Morisset S., et al. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 408:2000;860-864.
11. Bagnol D., et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19:1999;RC26.
12. Kas M.J.H., et al. Agouti-related protein prevents self-starvation. Mol. Psychiatry. 8:2003;235-240.
13. Harrold J.A., et al. Altered energy balance causes selective changes in melanocortin-4 (MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes. 48:1999;267-271.
14. Fekete C., et al. α-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J. Neurosci. 20:2000;1550-1558.
15. Hagan M.M., et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R47-R52.
16. Lu X.Y., et al. Time course of short-term and long-term orexigenic effects of Agouti-related protein (86-132). NeuroReport. 12:2001;1281-1284.
17. Kask A., Schioth H.B. Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Res. 887:2000;460-464.
18. Huszar D., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
19. Hinney A., et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84:1999;1483-1486.
20. Lubrano-Berthelier C., et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 12:2003;145-153.
21. Yeo G.S., et al. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum. Mol. Genet. 12:2003;561-574.
22. Daeffler L., Landry Y. Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential. Fundam. Clin. Pharmacol. 14:2000;73-87.
23. th Melanocortin Meeting, Sunriver, Oregon. 2002;. Abstr. S057.
24. Vink T., et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol. Psychiatry. 6:2001;325-328.
25. th Melanocortin Meeting, Sunriver, Oregon. 2002;. Abstr. S011.
26. Argyropoulos G., et al. A polymorphism in the human agouti-related protein is associated with late-onset obesity. J. Clin. Endocrinol. Metab. 87:2002;4198-4202.
27. Mayfield D.K., et al. A role for the Agouti-related protein promoter in obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 287:2001;568-573.
28. Parnot C., et al. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13:2002;336-343.
29. De Ligt R.A.F., et al. Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br. J. Pharmacol. 130:2000;1-12.
30. Han M., et al. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry. 37:1998;8253-8261.
31. Eberle A.N., et al. Antagonist and agonist activities of the mouse Agouti protein fragment (91-131) at the melanocortin-1 receptor. J. Recept. Signal Transduct. Res. 21:2001;25-45.
32. Graham A., et al. Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. Pigment Cell Res. 10:1997;298-303.
33. Geras-Raaka E., et al. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J. Exp. Med. 188:1998;405-408.
34. Rosenkilde M.M., et al. Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J. Biol. Chem. 274:1999;956-961.
35. Casarosa P., et al. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem. 276:2001;1133-1137.
36. Serre V., et al. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular adenosine 3′,5′-monophosphate levels and beta-cell glucose competence. Endocrinology. 139:1998;4448-4454.
37. Barsh G.S. The genetics of pigmentation: from fancy genes to complex traits. Trends Genet. 12:1996;299-305.
38. Robbins L.S., et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
39. Siracusa L.D. The agouti gene: turned on to yellow. Trends Genet. 10:1994;423-428.
40. Ollmann M.M., et al. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12:1998;316-330.
41. Vrieling H., et al. Differences in dorsal and ventral pigmentation result from regional expression of the mouse Agouti gene. Proc. Natl. Acad. Sci. U. S. A. 91:1994;5667-5671.
42. Yaswen L., et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5:1999;1066-1070.
43. Kim M.S., et al. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor. Peptides. 6:2002;1069-1076.